These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2327359)

  • 61. [Binary restenosis post-cutting balloon ptca before stenting].
    Flores JF; Villada JA; Ruiz EB; Hernández JS; Silvestre AM; Sandoval RA; Gallegos JE; Velasco AA; Campa JF
    Arch Cardiol Mex; 2006; 76(4):408-14. PubMed ID: 17315618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coronary stenting or balloon angioplasty for chronic total coronary occlusions: the Taiwan experience (a single-center report).
    Fang CC; Jao YT; Chen Y; Wang SP
    Angiology; 2005; 56(5):525-37. PubMed ID: 16193191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of adverse outcome 10 years after coronary angioplasty.
    Espinola-Klein C; Rupprecht HJ; Erbel R; Nafe B; Brennecke R; Meyer J
    J Invasive Cardiol; 1999 Dec; 11(12):722-8. PubMed ID: 10745472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Accelerated coronary artery stenosis at a site proximal to coronary angioplasty.
    Voyce SJ; Carey KT; Weiner BH; Laifer LI; Folland ED
    Cathet Cardiovasc Diagn; 1992 Jun; 26(2):113-6. PubMed ID: 1606598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Nakayama Y; Tsumura K; Yamashita N; Yoshimaru K; Hayashi T
    Circulation; 2000 Feb; 101(5):470-2. PubMed ID: 10662741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Arora RR; Konrad K; Badhwar K; Hollman J
    Cathet Cardiovasc Diagn; 1990 Jan; 19(1):17-22. PubMed ID: 2306759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
    Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistance of the atherosclerotic plaque during coronary angioplasty: a multivariate analysis of clinical and angiographic variables.
    Chenu P; Zakhia R; Marchandise B; Jamart J; Michel X; Schroeder E
    Cathet Cardiovasc Diagn; 1993 Jul; 29(3):203-9. PubMed ID: 8402843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Restenosis after coronary angioplasty.
    Anderson HV
    Dis Mon; 1993 Sep; 39(9):613-70. PubMed ID: 8359109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty.
    Bach R; Jung F; Kohsiek I; Ozbek C; Spitzer S; Scheller B; Dyckmans J; Schieffer H
    Thromb Res; 1994; 74 Suppl 1():S55-67. PubMed ID: 8073402
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of coronary angioplasty on the progression of coronary atherosclerosis.
    Rozenman Y; Gilon D; Welber S; Sapoznikov D; Lotan C; Mosseri M; Weiss T; Hasin Y; Gotsman MS
    Am J Cardiol; 1995 Dec; 76(16):1126-30. PubMed ID: 7484896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and the Risk for Restenosis After PTCA.
    Völzke H; Hertwig S; Rettig R
    Int J Angiol; 2000 Mar; 9(2):82-86. PubMed ID: 10758202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Arterial remodelling after percutaneous transluminal balloon angioplasty.
    Rozenman Y; Lotan C; Gilon D; Mosseri M; Sapoznikov D; Welber S; Gotsman MS
    Adv Exp Med Biol; 1993; 346():277-82. PubMed ID: 8184765
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Roguin A; Hochberg I; Nikolsky E; Markiewicz W; Meisel SR; Hir J; Grenadier E; Beyar R; Levy AP
    Am J Cardiol; 2001 Feb; 87(3):330-2, A9. PubMed ID: 11165970
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
    Nye ER; Ablett MB; Robertson MC; Ilsley CD; Sutherland WH
    Aust N Z J Med; 1990 Aug; 20(4):549-52. PubMed ID: 2222347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.
    Macdonald RG; Panush RS; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(3):56B-60B. PubMed ID: 2956845
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychologic predictors of psychosocial and medical outcomes in patients undergoing coronary angioplasty.
    Shaw RE; Cohen F; Fishman-Rosen J; Murphy MC; Stertzer SH; Clark DA; Myler RK
    Psychosom Med; 1986; 48(8):582-97. PubMed ID: 2949334
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty.
    Godfried SL; Deckelbaum LI
    Am Heart J; 1995 Jan; 129(1):203-10. PubMed ID: 7817919
    [No Abstract]   [Full Text] [Related]  

  • 79. Smokers undergoing percutaneous coronary revascularization present with fewer narrowings in the target coronary artery.
    Hasdai D; Rihal CS; Lerman A; Grill DE; Holmes DR
    Am J Cardiol; 1997 Nov; 80(9):1212-4. PubMed ID: 9359553
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma lipoproteins are not related to restenosis after successful coronary angioplasty.
    Rozenman Y; Gilon D; Welber S; Sapoznikov D; Lotan C; Geist M; Weiss AT; Hasin Y; Gotsman MS
    Am J Cardiol; 1993 Nov; 72(15):1206-7. PubMed ID: 8237817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.